Hot Posts5735- Page

Kolkata — long seen as outside India’s dominant startup corridors like Bengaluru, Mumbai and Delhi — is steadily carving out a distinct identity in the country’s entrepreneurial landscape. Founders building

Heart disease is no longer a distant, late-life risk—it is increasingly something that could affect you much earlier than expected. New data suggests that cardiac conditions are now showing up

Sun Pharma’s reported $12-billion bid for Organon & Co., if completed, would be among the largest overseas acquisitions by an Indian pharmaceutical company, bringing a global women’s health portfolio and